David James, Director of Patient Projects and Influencing at PCR talks to host Ben Monro-Davies about the National Screening Committee's draft recommendation that only those men who carry a BRCA1 or BRCA2 gene variant will be offered screening and what PCR will be doing next to ensure high-risk men get the early diagnosis they deserve.